|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
1983-8-17
|
|
pubmed:abstractText |
The anticancer effect and side effect of 1-(2-Tetrahydrofuryl)-5-fluorouracil (FH Fine granules "MI-TSUI") plus 5-FU Dry Syrup combination therapy was evaluated in 24 patients with cancer of the digestive organs. In this study, it was suggested that the daily oral administration of 400mg of FH Fine granules combined with 100mg of 5-FU Dry Syrup is most adequate and effective among them.
|
|
pubmed:language |
jpn
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
0385-0684
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
9
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
722-5
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:6820906-Adult,
pubmed-meshheading:6820906-Aged,
pubmed-meshheading:6820906-Blood Platelets,
pubmed-meshheading:6820906-Drug Therapy, Combination,
pubmed-meshheading:6820906-Female,
pubmed-meshheading:6820906-Fluorouracil,
pubmed-meshheading:6820906-Gastrointestinal Neoplasms,
pubmed-meshheading:6820906-Humans,
pubmed-meshheading:6820906-Male,
pubmed-meshheading:6820906-Middle Aged,
pubmed-meshheading:6820906-Tegafur
|
|
pubmed:year |
1982
|
|
pubmed:articleTitle |
[A clinical investigation of the combination therapy of 1-(2-tetrahydrofuryl)-5-fluorouracil (FH) fine granules and 5-FU dry syrup].
|
|
pubmed:publicationType |
Journal Article,
English Abstract
|
